No Pharma Money We do not accept funding from organizations that profit from the development or distribution of prescription drugs.

David Mitchell embraced by President Biden at the White House

News & Reports

The latest from P4ADNow

The latest news, research, policy analysis, and updates from the fight to lower prescription drug prices.

Latest
Explainers
For Press

News Nov 13, 2026

The Week in Review in Prescription Drug Pricing: P4AD CEO to Testify at Senate Judiciary Hearing, ETHIC Momentum Grows, and more

Our CEO Merith Basey will testify at Tuesday’s Senate Judiciary Committee hearing, “Prescribing Sunshine: How Competition & Transparency Lowers Prescription Drug Costs.” The hearing will focus on legislation to address the pharmaceutical industry’s abuse of the patent system — including through patent thickets, pay-for-delay deals, product hopping, and abuse of the citizen petition process.

Read The Full Story

Stay Up To Date

News and reports from P4ADNow

News Jul 15, 2021

Nearly 40 Labor, Business, Consumer, And Health Care Groups Support Medicare Negotiation For Lower Drug Prices

NEW JERSEY — Nearly 40 labor, business, consumer, and health care organizations sent a letter this week calling on Congress to pass legislation to allow Medicare to negotiate lower drug prices.

Read Article News Jul 15, 2021

Nearly 40 Labor, Business, Consumer, And Health Care Groups Support Medicare Negotiation For Lower Drug Prices

Nearly 40 labor, business, consumer, and health care organizations sent a letter this week calling on Congress to pass legislation to allow Medicare to negotiate lower drug prices.

Read Article News Jul 15, 2021

Nearly 40 Labor, Business, Consumer, And Health Care Groups Support Medicare Negotiation For Lower Drug Prices

Nearly 40 labor, business, consumer, and health care organizations sent a letter this week calling on Congress to pass legislation to allow Medicare to negotiate lower drug prices.

Read Article News Jul 15, 2021

Nearly 40 Labor, Business, Consumer, And Health Care Groups Support Medicare Negotiation For Lower Drug Prices

Nearly 40 labor, business, consumer, and health care organizations sent a letter this week calling on Congress to pass legislation to allow Medicare to negotiate lower drug prices.

Read Article News Jul 13, 2021

Massachusetts Patient Urges Legislators To Address High Drug Prices For Bay Staters

Patient advocate Karolina Chorvath, who lives with Crohn’s disease, shared her story about living with high drug prices today during a Joint Committee on Health Care Financing hearing, testifying in…

Read Article News Jul 12, 2021

The Week in Review in Prescription Drug Pricing

The House Committee on Oversight and Reform’s latest report undercutsthe drug industry’s biggest lie: That it needs high drug prices to fund meaningful innovation.

Read Article News Jul 9, 2021

President Biden’s Executive Order Drives Competition To Lower Drug Prices, The Administration Reaffirms Its Support For Legislation To Allow Medicare To Negotiate

The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now, in response to President Biden’s July 9 Executive Order on Promoting…

Read Article Reports Jul 8, 2021

New Report Reveals Big Pharma Spends More On Stock Buybacks, Dividends, And Executive Compensation Than Research And Development

The House Committee on Oversight and Reform released a new report today demonstrating that Big Pharma’s argument that the industry requires high drug prices to develop meaningful innovation is simply untrue.

Read Article News Jul 6, 2021

ICYMI: New Campaign Encourages Senator Carper To Support Medicare Negotiation

Patients For Affordable Drugs Now launched a campaign encouraging Senator Tom Carper (D-DE) to support legislation to lower drug prices by allowing Medicare negotiation.

Read Article News Jul 6, 2021

ICYMI: New Campaign Encourages Senator Menendez To Support Medicare Negotiation

NEW JERSEY — Patients For Affordable Drugs Now launched a six-figure campaign encouraging Senator Bob Menendez (D-NJ) to support legislation to lower drug prices by allowing Medicare negotiation.

Read Article

Explainers

Drug Pricing Explained

Videos breaking down the policies, practices, and decisions that shape what Americans pay for prescription drugs.

Patient advocate featured in The ETHIC Act Explained

The ETHIC Act Explained: What It Means for Patients

1:49 · Watch on YouTube

How Big Pharma Games the Patent System

3:50 · Watch on YouTube

Dr. Ramachandran discusses delays to Medicare drug price negotiation

Congress Delays Negotiation. Patients Pay the Price.

0:51 · Watch on YouTube

Help us spread the word

Subscribe To Our YouTube

For Press

Patients are available for interviews

Looking for a patient perspective or expert comment? We can connect you with patients, policy experts, and the latest research on prescription drug pricing.

[email protected]

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.